GERN is Geron Corporation (Healthcare) — a non-dividend-paying stock. Trading at $1.57. Market cap: $1.01B. Capital Quality Rank: 65/100 — Above average.
Stock snapshot
| Price | $1.57 |
| Market cap | $1.01B |
| Sector | Healthcare |
| Exchange | NMS |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 65 / 100 · Above average |
| ROIC (TTM) | -14.3% |
| Revenue CAGR (3y) | 575.7% |
| Shareholder buyback yield | -3.09% |
| Altman Z-score zone | Distress |
About GERN
Geron Corp is a biopharmaceutical company focused on blood cancers. Its telomerase inhibitor, RYTELO (imetelstat), is approved in the United States and European Union for certain adult patients with lower-risk myelodysplastic syndromes (LR-MDS) with transfusion-dependent anemia. RYTELO inhibits telomerase activity in malignant stem and progenitor cells, which may reduce abnormal cell proliferation while supporting the production of healthy cells. It is also conducting a Phase 3 trial of imetelstat in patients with JAK-inhibitor-refractory or relapsed myelofibrosis (R/R MF) and studies in other hematologic malignancies. The company operates as a single segment, being the development of therapeutic products for oncology.
Related non-dividend companies
Other non-dividend stocks investors research alongside GERN. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is GERN's current stock price?
GERN (Geron Corporation) is currently trading at $1.57.
Does GERN pay a dividend?
GERN (Geron Corporation) does not currently pay a regular dividend.
What is GERN's Capital Quality Rank?
GERN has a Capital Quality Rank of 65/100 — Above average. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track GERN in DiviDrip
Add GERN to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search GERN and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-06. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.